Cargando…

Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity

We sought to analyze the evolutionary characteristics and neutralization sensitivity of viruses in a human immunodeficiency virus type 1 (HIV-1) subtype B′ infected plasma donor with broadly neutralizing activity, which may provide information for new broadly neutralizing antibodies (bNAbs) isolatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yuanyuan, Zou, Sen, Wang, Zheng, Liu, Ying, Ren, Li, Hao, Yanling, Sun, Shasha, Hu, Xintao, Ruan, Yuhua, Ma, Liying, Shao, Yiming, Hong, Kunxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064334/
https://www.ncbi.nlm.nih.gov/pubmed/33805985
http://dx.doi.org/10.3390/vaccines9040311
_version_ 1783682112574980096
author Hu, Yuanyuan
Zou, Sen
Wang, Zheng
Liu, Ying
Ren, Li
Hao, Yanling
Sun, Shasha
Hu, Xintao
Ruan, Yuhua
Ma, Liying
Shao, Yiming
Hong, Kunxue
author_facet Hu, Yuanyuan
Zou, Sen
Wang, Zheng
Liu, Ying
Ren, Li
Hao, Yanling
Sun, Shasha
Hu, Xintao
Ruan, Yuhua
Ma, Liying
Shao, Yiming
Hong, Kunxue
author_sort Hu, Yuanyuan
collection PubMed
description We sought to analyze the evolutionary characteristics and neutralization sensitivity of viruses in a human immunodeficiency virus type 1 (HIV-1) subtype B′ infected plasma donor with broadly neutralizing activity, which may provide information for new broadly neutralizing antibodies (bNAbs) isolation and immunogen design. A total of 83 full-length envelope genes were obtained by single-genome amplification (SGA) from the patient’s plasma at three consecutive time points (2005, 2006, and 2008) spanning four years. In addition, 28 Env-pseudotyped viruses were constructed and their neutralization sensitivity to autologous plasma and several representative bNAbs were measured. Phylogenetic analysis showed that these env sequences formed two evolutionary clusters (Cluster I and II). Cluster I viruses vanished in 2006 and then appeared as recombinants two years later. In Cluster II viruses, the V1 length and N-glycosylation sites increased over the four years of the study period. Most viruses were sensitive to concurrent and subsequent autologous plasma, and to bNAbs, including 10E8, PGT121, VRC01, and 12A21, but all viruses were resistant to PGT135. Overall, 90% of Cluster I viruses were resistant to 2G12, while 94% of Cluster II viruses were sensitive to 2G12. We confirmed that HIV-1 continued to evolve even in the presence of bNAbs, and two virus clusters in this donor adopted different escape mechanisms under the same humoral immune pressure.
format Online
Article
Text
id pubmed-8064334
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80643342021-04-24 Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity Hu, Yuanyuan Zou, Sen Wang, Zheng Liu, Ying Ren, Li Hao, Yanling Sun, Shasha Hu, Xintao Ruan, Yuhua Ma, Liying Shao, Yiming Hong, Kunxue Vaccines (Basel) Article We sought to analyze the evolutionary characteristics and neutralization sensitivity of viruses in a human immunodeficiency virus type 1 (HIV-1) subtype B′ infected plasma donor with broadly neutralizing activity, which may provide information for new broadly neutralizing antibodies (bNAbs) isolation and immunogen design. A total of 83 full-length envelope genes were obtained by single-genome amplification (SGA) from the patient’s plasma at three consecutive time points (2005, 2006, and 2008) spanning four years. In addition, 28 Env-pseudotyped viruses were constructed and their neutralization sensitivity to autologous plasma and several representative bNAbs were measured. Phylogenetic analysis showed that these env sequences formed two evolutionary clusters (Cluster I and II). Cluster I viruses vanished in 2006 and then appeared as recombinants two years later. In Cluster II viruses, the V1 length and N-glycosylation sites increased over the four years of the study period. Most viruses were sensitive to concurrent and subsequent autologous plasma, and to bNAbs, including 10E8, PGT121, VRC01, and 12A21, but all viruses were resistant to PGT135. Overall, 90% of Cluster I viruses were resistant to 2G12, while 94% of Cluster II viruses were sensitive to 2G12. We confirmed that HIV-1 continued to evolve even in the presence of bNAbs, and two virus clusters in this donor adopted different escape mechanisms under the same humoral immune pressure. MDPI 2021-03-25 /pmc/articles/PMC8064334/ /pubmed/33805985 http://dx.doi.org/10.3390/vaccines9040311 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Hu, Yuanyuan
Zou, Sen
Wang, Zheng
Liu, Ying
Ren, Li
Hao, Yanling
Sun, Shasha
Hu, Xintao
Ruan, Yuhua
Ma, Liying
Shao, Yiming
Hong, Kunxue
Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
title Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
title_full Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
title_fullStr Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
title_full_unstemmed Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
title_short Virus Evolution and Neutralization Sensitivity in an HIV-1 Subtype B′ Infected Plasma Donor with Broadly Neutralizing Activity
title_sort virus evolution and neutralization sensitivity in an hiv-1 subtype b′ infected plasma donor with broadly neutralizing activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064334/
https://www.ncbi.nlm.nih.gov/pubmed/33805985
http://dx.doi.org/10.3390/vaccines9040311
work_keys_str_mv AT huyuanyuan virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT zousen virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT wangzheng virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT liuying virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT renli virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT haoyanling virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT sunshasha virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT huxintao virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT ruanyuhua virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT maliying virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT shaoyiming virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity
AT hongkunxue virusevolutionandneutralizationsensitivityinanhiv1subtypebinfectedplasmadonorwithbroadlyneutralizingactivity